Therapeutic strategies aimed at modulating glial activation states (69) (e.g., restoring M2 or A2 phenotypes), blocking inflammatory signaling (e.g., TGF-β, PECAM1), or reinforcing BBB structural integrity may hold promise for mitigating CNS complications in sepsis. Here, TGFB1 is linked to Sepsis.